We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?
- Authors
Kronbichler, Andreas; Mayer, Gert
- Abstract
Implication for health policy/practice/research/medical education: Reports on patients with steroid-dependent nephrotic syndrome and underlying minimal change disease or focal segmental glomerulosclerosis have shown promising results. There is a strong need for more trials conducted in a prospective, controlled manner to clearly recommend rituximab therapy in this indication on a regular basis.
- Subjects
NEPHROTIC syndrome; MONOCLONAL antibodies; ELECTROMAGNETIC waves; SPECTRUM analysis; CHANGE blindness
- Publication
Journal of Nephropathology, 2014, Vol 3, Issue 1, p1
- ISSN
2251-8363
- Publication type
Article
- DOI
10.12860/jnp.2014.01